Impact of Computer-aided Detection System on the Proximal Adenoma Miss Rate

December 17, 2025 updated by: Nanfang Hospital, Southern Medical University

Impact of Computer-aided Detection System on the Proximal Adenoma Miss Rate: a Multicenter Tandem Rondomized Controlled Trial

This is a prospective, multicenter randomized controlled trial designed to determine whether the use of computer-aided detection system could reduce the miss rates of adenomas, SSLs, and polyps in the proximal colon during tandem colonoscopy.

Study Overview

Detailed Description

  1. Study Centers 1) Nanfang Hospital, Southern Medical Univerisity, Guangzhou, China 2) The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China 3) Longgang District People's Hospital of Shenzhen, Shenzhen, China 4) Yangjiang People's Hospital, Yangjiang, China 5) Jiangmen Central Hospital, Jiangmen, China 6) Huizhou Third People's Hospital, Huizhou, China 7) Dongguan Shuixiang Central Hospital, Dongguang, China 8) Pingshan District People's Hospital of Shenzhen, Shenzhen, China
  2. Study population 1) Inclusion criteria:

    1. Patients age 40-75 years old, regardless of gender
    2. Patients presenting for physical examination, colorectal cancer screening or diagnosis
    3. Patients voluntarily signs an informed consent form 2) Exclusion criteria:
    1. Unable to cooperate ot tolerate colonoscopy
    2. History of inflammatory bowel disease
    3. History of colorectal cancer
    4. Previous colorectal surgery
    5. History of recurrent constipation
    6. Taking anticoagulant and antiplatelet drugs berfore procedure
    7. High risk conditions such as severe cardiovascular and cerebrovascular diseases, severe anemia, or uncorrected infections
    8. Pregnant or lactating women Researchers concluded that patient was not suitable to participate in this trial.

      3) Post-randomization exclusion criteria:

    1. Cecum could not be intubated for various reasons
    2. Boston Bowel Preparation Scale (BBPS) score of the proximal colon is <2
  3. Study design This is a prospective , multicenter randomized controlled trial comparing the miss rates of proximal colonic lesions (including adenomas, SSLs, and polyps) by computer-aided detection-assisted colonoscopy or conventional colonoscopy. The study will be conducted in the Endoscopy Centre of the participating hospitals.
  4. Randomization 1) Eligible patients at each center will be randomized (1:1) to computer-aided detection-assisted colonoscopy first or conventional white light colonoscopy first, followed immediately by the other procedure in tandem fashion by the same endoscopist. The proximal colon is defined as the colonic segment proximal to the hepatic flexure.

2) Randomization will be performed using computer-generated random sequences in blocks of 6, with stratification by academic level of participation center, experience of endoscopists, and indications of colonoscopy. Patients will be blinded to their group assignment.

Study Type

Interventional

Enrollment (Estimated)

686

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510515
        • Nanfang Hospital, Southern Medical University
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patients age 40-75 years old, regardless of gender
  2. Patients presenting for physical examination, colorectal cancer screening or diagnosis
  3. Patients voluntarily signs an informed consent form

Exclusion Criteria:

  1. Unable to cooperate ot tolerate colonoscopy
  2. History of inflammatory bowel disease
  3. History of colorectal cancer
  4. Previous colorectal surgery
  5. History of recurrent constipation
  6. Taking anticoagulant and antiplatelet drugs berfore procedure
  7. High risk conditions such as severe cardiovascular and cerebrovascular diseases, severe anemia, or uncorrected infections
  8. Pregnant or lactating women Researchers concluded that patient was not suitable to participate in this trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computer-aided detection-assisted colonoscopy
Tandem colonoscopy of proximal colon assisted with computer-aided detection system followed by conventional white-light colonoscopy
Computer-aided detection-assisted colonoscopy for detection of colonic polyp
Active Comparator: Conventional white-light colonoscopy
Tandem conventional white-light colonoscopy of proximal colon followed by usual computer-aided detection-assisted colonoscopy
Conventional white-light colonoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proximal adenoma missed rate
Time Frame: One day
The number of adenomas identified during the second right colon inspection divided by the overall number of adenomas identified during the first and second right colon inspection.
One day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proximal polyp missed rate
Time Frame: One day
The number of polyps identified during the second right colon inspection divided by the overall number of polyps identified during the first and second right colon inspection.
One day
Proximal SSLs missed rate
Time Frame: One days
The number of SSLs identified during the second right colon inspection divided by the overall number of SSLs identified during the first and second right colon inspection.
One days
Proximal advanced adenoma missed rate
Time Frame: One day
The number of advanced adenomas identified during the second right colon inspection divided by the overall number of advanced adenomas identified during the first and second right colon inspection.
One day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

December 17, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Actual)

December 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Adenomas

Clinical Trials on Computer-aided detection-assisted colonoscopy

Subscribe